Refine by
Nanoparticle Articles & Analysis: This-Year
6 news found
For more information on CD Bioparticles' custom Bio-Targeted Small Molecules Conjugated Magnetic Nanoparticles synthesis services, please visit https://www.cd-bioparticles.com/services/bio-targeted-small-molecules-conjugated-magnetic-nanoparticles.html. About CD Bioparticles CD Bioparticles specializes in manufacturing and supplying nanoparticles, ...
About CD Bioparticles CD Bioparticles specializes in manufacturing and supplying nanoparticles, microparticles, and coatings for diagnostics and research, alongside developing customized, biocompatible drug delivery systems. We offer diverse formulation technologies (from liposomes to polymer nanoparticles) and comprehensive services, including surface ...
The HZ-PEG-HZ (1K) product is critical for applications including: l Controlled Drug Delivery Systems: Leveraging its pH-sensitive hydrazone bonds for targeted and controlled release of active pharmaceutical ingredients in specific physiological environments (e.g., tumor microenvironments, endosomes, lysosomes). l Bioconjugation and Crosslinking: Facilitating the creation of stable linkages in ...
l Oral Thin Films: Fast dissolving method to make patient’s compliance easy by giving easy to use. l Microencapsulation Systems: Guarding actives and allowing for controlled release. l Nanoparticle Development: Solubility enhancement, tissue specificity to get best result from treatment. l Vesicular Systems Engineering: Liposomal and niosomal formulations with enhanced ...
CD Bioparticles provides a range of endotoxin free silver nanoparticles with sizes varying from 10 nm to 100 nm. These high-purity (>99%) nanoparticles exhibit low endotoxin levels. ...
It specializes in various formulation and drug delivery technologies, from conventional liposomes and PEGylated liposomes to polymer microspheres and nanoparticles for drug delivery. The company also provides contract research services for drug delivery formulation, formulation feasibility study, process development and scale-up, as well as analytical and non-clinical research ...